Replies to post #9995 on Momenta Pharmaceuticals, Inc. (MNTA)

[DewDiligence]

Re: Valuation arithmetic

If the arithmetic in #msg-81550668 is valid, MNTA’s Lovenox royalties—assuming no help whatsoever from the legal system—are worth about $3/share. Inasmuch as cash on hand is approximately $7/share, shareholders are currently paying essentially zero for the rest of the company.